Martin A Langston
Physical Medicine & Rehabilitation · Pineville, LANPI 1821087917
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 222 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 15.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,281 and has fallen 55.3% since, to $572 in 2023.
Across 222 payments — averaging $19.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$662
- Medtronic$491
- AbbVie$474
- Collegium Pharmaceutical, Inc.$454
- Amgen$442
- Pfizer$203
- plus $2K from 26 others
Across 1 payment — averaging $820.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$820
What the payments were for
- Food & beverage$4,348100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 29 | $662 |
| Medtronic(2 entities) | 13 | $491 |
| AbbVie(2 entities) | 36 | $474 |
| Collegium Pharmaceutical, Inc. | 27 | $454 |
| Amgen | 30 | $442 |
| Pfizer | 15 | $203 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 11 | $192 |
| Si-bone, Inc. | 2 | $179 |
| Daiichi Sankyo Inc. | 4 | $147 |
| Relievant Medsystems, Inc. | 1 | $143 |
| Merz Pharmaceuticals, LLC | 6 | $127 |
| Ipsen Biopharmaceuticals, Inc | 6 | $111 |
| Stryker | 4 | $99 |
| Scilex Pharmaceuticals Inc. | 7 | $96 |
| MDD US Operations, LLC | 5 | $79 |
| Arbor Pharmaceuticals, Inc. | 4 | $57 |
| Saol Therapeutics Inc. | 1 | $54 |
| Averitas Pharma Inc. | 2 | $44 |
| Almatica Pharma LLC | 3 | $42 |
| Kowa Pharmaceuticals America, Inc. | 2 | $34 |
| Virtus Pharmaceuticals LLC | 2 | $34 |
| Assertio Therapeutics, Inc. | 2 | $24 |
| Azurity Pharmaceuticals, Inc. | 1 | $20 |
| Boston Scientific | 1 | $17 |
| Redhill Biopharma Inc. | 1 | $17 |
| Merz North America, Inc. | 1 | $16 |
| Stimwave Technologies Incorporated | 1 | $16 |
| Biohaven Pharmaceuticals, Inc. | 1 | $15 |
| Shionogi Inc | 1 | $15 |
| Biodelivery Sciences International, Inc. | 1 | $15 |
| Zyla Life Sciences, Inc. | 1 | $15 |
| Nalu Medical, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intracept$286
- INTELLIS ADAPTIVESTIM$267
- Proclaim IPG$143
- iFuse Implant$135
- Proclaim XR IPG$131
- Morphabond ER$125
How this compares
$4,348 in reported general payments places this provider in the 80th percentile of 117 physical medicine & rehabilitation providers in Louisiana.
See all physical medicine & rehabilitation providers in Louisiana →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 26 | $288 |
| Meloxicam | 13 | $32 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Pineville
- William RogenmoserAlexandria$350K
- Andrea ToomerMarrero$170K
- Taylor ColonCovington$26K
- Erik DavisMetairie$12K
- Stephen RynickMarrero$12K
- Fred DefranceschMetairie$11K
- Eric FinckeNew Orleans$9K
- Casey MurphyNew Orleans$8K
- Joshua KaufmanNew Orleans$8K
- Navneet SharmaRuston$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.